The art and science of drug formulation - Drug Target Review
Aug 9, 2024 · Drug formulation is a cornerstone of modern medicine, turning raw active ingredients into consumable, effective therapies. This critical phase in drug development …
New AI model may enable more targeted prostate cancer treatment
Oct 30, 2024 · The researchers demonstrated that the AI model could locate and measure around 85 percent of prostate tumours that had a Prostate Imaging Reporting and Data System (PI …
Immuno-oncology innovations redefining cancer treatment in 2024
Jan 23, 2024 · Dr Espen Basmo Ellingsen. University of Oslo . Dr Ellingsen is a Medical Doctor and holds a PhD in cancer immunology from the University of Oslo. Background in …
How AI will reshape pharma in 2025 - drugtargetreview.com
Dec 20, 2024 · Artificial intelligence (AI) has revolutionised many industries, yet its adoption in pharmaceutical drug development has been notably slower. Concerns surrounding data …
The promise of vectors targeting the LDL receptor - Drug Target …
Jun 4, 2024 · What is the mechanism underlying RNA interference (RNAi) and how does it contribute to gene silencing in mammalian cells? The underlying mechanism of RNAi is based …
Tessera Therapeutics: addressing Alpha-1 Antitrypsin Deficiency
Jun 18, 2024 · Mike Holmes, PhD, Chief Scientific Officer at Tessera Therapeutics. Michael joined Tessera in December 2021 as Chief Scientific Officer. Dr Holmes has over 20 years of …
Developing an effective vaccine for herpes simplex virus
Feb 13, 2024 · Co-corresponding author Dr David Leib, chair and professor of microbiology and immunology at Geisel, explained: “Despite three decades of trying, the scientific community …
Overcoming obstacles in personalised medicine
Dec 11, 2024 · Seth Lederman is a physician, scientist and entrepreneur, and a co-founder of Tonix Pharmaceuticals. Prior to Tonix, Dr Lederman founded Targent Pharmaceuticals, which …
Eurofins Discovery - Drug Target Review
Integrated Drug Discovery.The DiscoveryOne™ integrated drug discovery team works hand-in-hand as partners with you, integrating all Eurofins Discovery capabilities to accelerate delivery …
The promise of 3A5C7 mAb in the treatment of morphine tolerance
Jan 30, 2024 · Morphine is a frequently used analgesic that activates the mu-opioid receptor (MOR), which has prominent side effects of tolerance. A monoclonal antibody (mAb) precisely …